Please login to the form below

Not currently logged in
Email:
Password:

Ovarian canncer

This page shows the latest Ovarian canncer news and features for those working in and with pharma, biotech and healthcare.

Another NICE no for AZ’s new ovarian cancer drug

Another NICE no for AZ’s new ovarian cancer drug

Another NICE no for AZ’ s new ovarian cancer drug. Cost watchdog wants more information for Lynparza. ... People who have BRCA 1 or 2 gene mutations have an increased risk of ovarian cancer.

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Say Communications

Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics